The autosomal recessive inherited primary hyperoxalurias types I, II and III are caused by defects in glyoxylate metabolism that lead to the endogenous overproduction of oxalate. Type III primary ...

Primary hyperoxaluria type 1 (PH1) is one of a group of rare diseases that are genetic, or inherited from your parents. Primary hyperoxalurias affect your metabolism -- your body's process for turning ...

An investigator-initiated trial examining YolTech Therapeutics’ in vivo gene editing-based ‘life-long cure’ for patients ...

Over the past 20 years, we analyzed stones obtained from 74 patients with a diagnosis of primary hyperoxaluria type 1 established on the basis of complete urinary biochemical tests and evidence of an ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. During clinical trials, patients treated with Rivfloza ...

Credit: Getty Images. Rivfloza is a small interfering RNA therapeutic. The Food and Drug Administration (FDA) has approved Rivfloza™ (nedosiran) to lower urinary oxalate levels in children 9 years of ...

Researchers gaining a better understanding of the genetic basis for oxalate absorption. Nephrolithiasis results from an interaction between diet and genetic predisposition. Most renal stones contain ...

New York, USA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading Companies - Alnylam Pharmaceuticals, Dicerna ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA has approved Alnylam ...